Clinical trials
Not yet recruiting Coronary Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China Academy of Chinese Medical Sciences | 2 |
| Nanjing First Hospital, Nanjing Medical University | 2 |
| Nanjing Medical University | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Beijing Anzhen Hospital | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Lepu Medical Technology (Beijing) Co., Ltd. | 1 |
| Qilu Hospital of Shandong University | 1 |
| Shanghai 10th People's Hospital | 1 |
| Shanghai Zhongshan Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Disease | 14 |
| Arrhythmias, Cardiac | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Heart Failure | 1 |
| Heart Valve Diseases | 1 |
| Hypertrophy, Left Ventricular | 1 |
| Inflammation | 1 |
| Myocardial Infarction | 1 |
| Shock, Cardiogenic | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.